Fourier transform infrared (FT-IR) spectroscopy is a non-destructive and sensitive method for studying the higher-order structure of proteins/peptides, which is widely used in various fields such as biotechnology, biochemistry, and pharmaceuticals. It provides valuable information about the stability of proteins under different conditions, making it an important tool for protein/peptide research. With decades of rich experience in developing and performing FT-IR analytical methods, CD Formulation uses FT-IR spectroscopy to provide reliable analytical support for the development and characterization of your protein/peptide drugs, from early development to late product release testing.
FTIR is a spectral technology based on infrared photon absorption. This photon will stimulate the vibration of the molecular keys, and the characteristic spectrum generated is generated to help identify and represent samples. FTIR analysis can be performed in transmission or reflex mode. Although this method cannot provide accurate atomic resolution molecular structures, it is very sensitive to the changes in the conformity changes when protein changes between functional transformation or between molecular. Its working principle is the light that detects specific frequencies corresponding to internal vibration bonds to the molecule. When the vibration energy matches the medium infrared light, the key will absorb the energy. Because different keys are vibrated with different energy, they will absorb infrared radiation of different wavelengths. The ex -spectrum and its respective absorption bands in terms of position and strength form a unique molecular fingerprint.
Fig. 1 Schematic presentation of the infrared experimental setup. (Bakshi K, et al., 2014)
The principle of FTIR spectroscopy is based on the vibration and rotation of atoms in the internal structure of proteins and peptides. When infrared radiation passes through the sample, the protein molecules absorb the radiation energy of a specific wavelength, which is the spectral value. By comparing the measured spectrum with a spectral database, FTIR spectroscopy can be used to identify the protein or peptide of interest.
In FTIR analysis, the fingerprint FTIR spectrum of protein and peptides absorbs the telescopic vibration of the amide I and the amide II.
The amide I band (1690-1600 cm−1) is caused by the C=O stretching vibration of the peptide bond and is modulated by the secondary structure (α-helix, β-sheet, etc.). The secondary structure content can be obtained by comparing the measured spectrum with the spectrum of proteins with known secondary structure.
The amide II band (1600-1500 cm−1) is formed by the CN stretching vibration combined with the NH bending. The amide II absorbance can be used to report the protein unfolding.
Fig. 2 FTIR spectrum of a typical protein illustrating the Amide I and Amide II bands at ~1650 cm−1 and ~1540 cm−1, respectively.(Miller LM, et al., 2013)
Thanks to decades of experience in supporting protein/peptide biopharmaceutical development and manufacturing using FT-IR technology, our team of highly qualified experts offers a range of FT-IR-related services to accelerate the implementation and success of your projects.
Our experienced team of experts has completed hundreds of protein and peptide FT-IR analysis projects, allowing support for all stages of your protein/peptide drug development and manufacturing - from early research to downstream process monitoring and GMP batch release testing.
Utilizing cutting-edge FT-IR technology, we support the following protein/peptide characterization programs, including but not limited to:
Protein and peptide HOS characterization is one of the main applications of FT-IR in protein and peptide drug characterization. Our scientists determine the structural characteristics of proteins and peptides by measuring a series of characteristic infrared absorption bands (fingerprint FTIR spectrum absorption bands of proteins and peptides).
The correspondence between the typical infrared values of amides I, II, and III in protein and peptide structure and the secondary structure is:
Conformation | The position of bands and peaks within Ⅰ-Ⅲ region |
a-helix β-sheet B-turn Random coil Aggregated protein |
Amide I band 1649;1653-1657;1655 1621-1623;1630;1634-1639;1647-1648;1680-1691(B-sheet or β-turn) 1661;1667;1673;1677 1648;1654;1642-1657 1615-1620 |
a-helix β-sheet B-turn |
Amide ll band 1545 1530 1528; 1577 |
a-helix β-sheet unordered + turn |
Amide Ill band 1293;1300-1311;1316-1320;1331 1223-1225;1231-1238;1242;1248-1251 1244;1259-1269;1280-1290 |
Identifying and quantifying the aggregation is an important test program in the development of protein and peptide therapy agents because the agglomeration will affect the effect of drugs and cause immunogenic reactions. Our scientists use FT-IR to accurately identify and quantify different forms of aggregation in the process of drug storage, formulation, and manufacturing to accelerate your drug development process.
Understanding changes in protein structure is essential for evaluating its stability and function. Our scientists obtain the structural information of proteins and peptides under different conditions by analyzing specific peaks in the FT-IR spectrum, such as pH, temperature or chemical modification, etc.
Water interferes with FTIR measurements of protein samples because it absorbs strongly in the amide I region. When analyzing your protein or peptide sample, our scientists will first consider converting it into a lyophilized (freeze-dried) sample. For samples that can‘t be lyophilized, we will measure them by transmission infrared (IR) spectroscopy and attenuated total reflectance (ATR) enhanced FTIR spectroscopy. However, this requires a relatively high protein concentration (usually >5 mg/mL).
The transmission IR spectroscopy is a spectrum detected after transmitting infrared light through the sample, which is suitable for solid, liquid, and gas samples. In this technology, protein samples are placed in a special sample box and then measured by a bouquet of infrared light. This light interacts with chemical bonds in proteins, which produces a unique spectral diagram.
ATR is a technique that places the sample directly on the ATR crystal for spectral testing, which can effectively reduce the sample preparation process and improve the speed and accuracy of analysis. This method does not require sample processing and is suitable for samples that need to be analyzed quickly.
In addition to the above-mentioned FT-IR spectroscopy analysis, our analytical laboratory is also equipped with a state-of-the-art FTIR microscope, a device that combines the functionality of an optical microscope with the analytical capabilities of FTIR spectroscopy to support the visualization analysis of particles in your protein/peptide biopharmaceutical samples.
Published Data
Technology: In-Line FT-IR Spectroscopy
Journal: Journal of chromatography A.
IF: 3.8
Published: 2018
Results:
The authors describe the application of online FTIR spectroscopy as a process analytical technology (PAT) tool during downstream processing. The FTIR instrument was coupled to a laboratory-scale preparative chromatography system for experiments. It was applied to selective protein quantification, PEGylated lysozyme species separation, and monitoring of process-related impurities. All results show that online FTIR has the potential to be a powerful PAT tool for monitoring protein chromatography. The figure below shows the monitoring of a process-related impurity, Triton X-100, a non-ionic surfactant used for viral inactivation of biopharmaceuticals, by online FTIR during a chromatographic run.
Fig. 3 Triton X-100 as a process-related impurity can be seen in the flow-through of the cation-exchange experiment from 5.5 ml to 11 ml at 1090 cm−1. (Großhans S, et al., 2018)
CD Formulation aims to provide a powerful analytical tool for protein and peptide HOS (secondary, tertiary) characterization. Please feel free to contact us if you are interested in our services. Learn how our FT-IR spectroscopy technology can support the smooth implementation of your protein/peptide biopharmaceutical program.
References